0,789  0,017  Antiinflammatory
0,663  0,015  CYP2C9 substrate
0,640  0,009  Cardiovascular analeptic
0,640  0,010  Antineoplastic (melanoma)
0,629  0,008  Antipruritic, allergic
0,616  0,006  UGT1A4 substrate
0,610  0,021  Alzheimer's disease treatment
0,578  0,016  Immunosuppressant
0,582  0,031  CYP3A4 substrate
0,537  0,039  Transcription factor NF kappa B inhibitor
0,535  0,038  TNF expression inhibitor
0,498  0,005  Acaricide
0,506  0,015  Nitric oxide antagonist
0,496  0,021  Antiepileptic
0,512  0,038  Antileukemic
0,445  0,004  TRPA1 agonist
0,445  0,006  Pneumotoxic
0,466  0,028  FMO1 substrate
0,462  0,025  Sensitization
0,454  0,020  Antipyretic
0,457  0,027  Analeptic
0,445  0,021  UGT2B4 substrate
0,447  0,039  Ulceration
0,478  0,069  Caspase 9 stimulant
0,419  0,014  Anesthetic general
0,441  0,039  Bone diseases treatment
0,405  0,004  Vanilloid agonist
0,409  0,010  UGT2B7 substrate
0,426  0,028  NOS2 expression inhibitor
0,477  0,081  Apoptosis agonist
0,393  0,011  Antipruritic, non-allergic
0,394  0,017  Skin irritative effect
0,438  0,061  Antibacterial
0,410  0,035  CTGF expression inhibitor
0,388  0,017  Antiparkinsonian, rigidity relieving
0,390  0,020  Sodium/bile acid cotransporter inhibitor
0,395  0,026  Calcium channel activator
0,386  0,020  Eye irritation, high
0,408  0,043  Respiratory analeptic
0,403  0,039  Spasmolytic
0,402  0,040  CYP2C19 substrate
0,401  0,041  Antipsoriatic
0,395  0,042  ICAM1 expression inhibitor
0,353  0,006  UGT2B9 substrate
0,356  0,014  Interferon gamma antagonist
0,380  0,042  Antiosteoporotic
0,353  0,018  Antihypotensive
0,341  0,007  Antifungal enhancer
0,354  0,022  UGT1A1 substrate
0,354  0,023  RNA-directed DNA polymerase inhibitor
0,375  0,045  NOS3 expression inhibitor
0,344  0,018  Antiseptic
0,340  0,015  Prostate disorders treatment
0,354  0,032  Antiparasitic
0,337  0,017  Antiacne
0,334  0,018  VCAM1 expression inhibitor
0,388  0,072  GST A substrate
0,324  0,011  Acetylcholinesterase inhibitor
0,341  0,028  5 Hydroxytryptamine uptake stimulant
0,333  0,020  Tyrosine 3 hydroxylase inhibitor
0,339  0,032  Interleukin agonist
0,364  0,059  Cholesterol antagonist
0,348  0,044  Antineoplastic (non-small cell lung cancer)
0,352  0,052  Antihypercholesterolemic
0,324  0,027  Antihelmintic
0,343  0,046  Chemoprotective
0,317  0,020  Melanin inhibitor
0,342  0,049  Interleukin 2 agonist
0,332  0,040  Hypolipemic
0,309  0,018  Cholinergic
0,330  0,040  Mutagenic
0,380  0,093  Analgesic
0,325  0,043  Transcription factor STAT inhibitor
0,320  0,039  Chemopreventive
0,290  0,010  SULT1A3 substrate
0,284  0,005  HIV-1 integrase (Strand Transfer) inhibitor
0,336  0,057  Lipoprotein disorders treatment
0,315  0,038  GST M1-1 substrate
0,309  0,033  Abortion inducer
0,294  0,022  Anesthetic
0,283  0,013  DNA polymerase I inhibitor
0,319  0,048  Cytotoxic
0,317  0,047  Proliferative diseases treatment
0,363  0,094  Histamine release inhibitor
0,271  0,005  HIV-1 integrase (3'-Processing) inhibitor
0,311  0,047  Antineoplastic (liver cancer)
0,326  0,062  Nootropic
0,307  0,044  Carcinogenic
0,282  0,024  CYP2B6 inhibitor
0,293  0,038  Gastrin inhibitor
0,302  0,048  Angiogenesis stimulant
0,301  0,051  Antineoplastic (renal cancer)
0,266  0,017  Insulin secretagoues
0,319  0,071  AR expression inhibitor
0,253  0,005  Vanilloid 1 agonist
0,279  0,033  Non-steroidal antiinflammatory agent
0,267  0,022  Protein kinase stimulant
0,281  0,038  Sedative
0,303  0,061  Teratogen
0,289  0,047  UGT1A6 substrate
0,353  0,112  5 Hydroxytryptamine release inhibitor
0,291  0,052  Antiglaucomic
0,312  0,075  Antifungal
0,299  0,061  UGT1A9 substrate
0,248  0,012  Farnesoid X receptor antagonist
0,312  0,077  Antineoplastic (colorectal cancer)
0,278  0,043  Sigma receptor agonist
0,242  0,011  Microtubule formation inhibitor
0,326  0,095  Toll-Like receptor agonist
0,260  0,030  Antianorexic
0,325  0,096  Antiasthmatic
0,286  0,062  Antineoplastic (glioma)
0,273  0,050  Psychostimulant
0,238  0,017  UGT2B10 substrate
0,277  0,057  Acute neurologic disorders treatment
0,291  0,072  CYP1A2 substrate
0,223  0,006  Inducible nitric-oxide synthase inhibitor
0,289  0,073  Antineoplastic (pancreatic cancer)
0,296  0,082  Antineoplastic (endocrine cancer)
0,251  0,038  Neurotrophic factor enhancer
0,300  0,088  Antithrombotic
0,277  0,065  Embryotoxic
0,242  0,036  Lipocortins synthesis antagonist
0,235  0,031  UGT2B15 substrate
0,312  0,108  GABA C receptor rho-3 antagonist
0,225  0,022  ATPase inhibitor
0,251  0,049  UDP-glucuronosyltransferase substrate
0,240  0,038  Prostatic (benign) hyperplasia treatment
0,219  0,018  Arachidonic acid antagonist
0,222  0,022  Cholesterol synthesis inhibitor
0,280  0,083  Antineoplastic (colon cancer)
0,213  0,016  SULT1A1 substrate
0,217  0,022  Antirickettsial
0,246  0,059  Anticonvulsant
0,223  0,035  Antipruritic
0,217  0,034  CNS active muscle relaxant
0,193  0,010  Posttraumatic stress disorder treatment
0,199  0,017  Choleretic
0,254  0,073  Antineoplastic (cervical cancer)
0,295  0,114  Toll-Like receptor 7 agonist
0,193  0,022  GABA C receptor agonist
0,205  0,034  Uterine stimulant
0,214  0,044  UGT1A3 substrate
0,197  0,029  Raynaud's phenomenon treatment
0,189  0,023  Expectorant
0,283  0,118  Stroke treatment
0,207  0,046  VEGF expression inhibitor
0,247  0,085  Antioxidant
0,188  0,027  Autism spectrum disorders treatment
0,219  0,058  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,185  0,025  Cyclooxygenase 3 inhibitor
0,273  0,113  Antineoplastic (lung cancer)
0,185  0,027  Movement disorders treatment
0,222  0,066  Antialcoholic
0,186  0,031  Antihyperlipoproteinemic
0,169  0,015  Actinic keratosis treatment
0,168  0,014  Opioid kappa receptor antagonist
0,198  0,045  Phospholipase C inhibitor
0,187  0,036  Anesthetic local
0,268  0,116  Vasodilator, coronary
0,243  0,092  5 Hydroxytryptamine release stimulant
0,162  0,012  Anabolic
0,155  0,006  ATPase (Vacuolar H+) inhibitor
0,154  0,006  Hyperparathyroidism treatment
0,154  0,007  5-Alpha-reductase inhibitor
0,230  0,083  DNA synthesis inhibitor
0,198  0,051  Antihelmintic (Nematodes)
0,168  0,023  UGT2B1 substrate
0,175  0,030  Adenylate cyclase stimulant
0,176  0,032  Antifungal (Cryptococcus)
0,173  0,031  GST P1-1 substrate
0,189  0,047  Antiparkinsonian, tremor relieving
0,190  0,048  Antiviral (Influenza A)
0,155  0,013  UGT2B11 substrate
0,162  0,021  Ca2+-transporting ATPase inhibitor
0,160  0,019  Nitric-oxide synthase inhibitor
0,229  0,090  Superoxide dismutase inhibitor
0,187  0,049  Amylase inhibitor
0,234  0,097  Transcription factor STAT3 inhibitor
0,162  0,025  Photosensitizer
0,219  0,083  Cytostatic
0,185  0,051  Diuretic
0,154  0,020  Prolactin inhibitor
0,236  0,102  Immunostimulant
0,320  0,187  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,259  0,127  Antineoplastic (small cell lung cancer)
0,168  0,036  Retinoprotector
0,193  0,061  LDLR expression enhancer
0,190  0,060  Antineoplastic (gastric cancer)
0,241  0,111  FMO3 substrate
0,158  0,028  Contraceptive female
0,183  0,053  Neuropathy treatment
0,188  0,059  Antimutagenic
0,154  0,025  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,166  0,038  Proteasome inhibitor
0,145  0,018  CYP2A6 inhibitor
0,177  0,050  Carcinogenic, group 1
0,172  0,048  Antiprotozoal (Coccidial)
0,186  0,062  Succinate dehydrogenase inhibitor
0,217  0,096  Aldehyde oxidase inhibitor
0,203  0,082  Antimitotic
0,185  0,065  Muscle relaxant
0,150  0,031  Antineoplastic antibiotic
0,283  0,165  Transcription factor inhibitor
0,159  0,042  Alkylator
0,224  0,108  Radioprotector
0,139  0,023  GST T1-1 substrate
0,141  0,025  Androgen antagonist
0,131  0,016  Aromatase inhibitor
0,188  0,073  Hepatoprotectant
0,144  0,031  Sulfotransferase substrate
0,230  0,117  Antihypoxic
0,167  0,054  Genotoxic
0,161  0,049  Alpha-N-acetylglucosaminidase inhibitor
0,121  0,010  Anticholelithogenic
0,161  0,050  Carcinogenic, group 3
0,254  0,143  Antineoplastic (breast cancer)
0,137  0,028  Antiprotozoal (Toxoplasma)
0,185  0,075  P-glycoprotein inhibitor
0,160  0,052  Hearing loss treatment
0,167  0,059  Hair growth stimulant
0,227  0,120  CYP2D6 substrate
0,191  0,084  Histone acetyltransferase inhibitor
0,130  0,023  Tourette's syndrome treatment
0,133  0,027  Antiviral (SARS coronavirus)
0,133  0,027  Antiviral (Coronavirus)
0,174  0,068  Phobic disorders treatment
0,118  0,013  Glycine receptor agonist
0,279  0,175  Calcium channel L-type activator
0,192  0,090  Antineoplastic (glioblastoma multiforme)
0,124  0,023  Ornithine decarboxylase inhibitor
0,151  0,051  Pregnane X receptor agonist
0,137  0,038  GABA C receptor antagonist
0,110  0,011  Protein 50S ribosomal subunit inhibitor
0,109  0,010  Antimycoplasmal
0,115  0,016  SULT1A2 substrate
0,195  0,097  Nitric-oxide synthase stimulant
0,124  0,028  Paget's disease treatment
0,098  0,003  Parathyroid hormone antagonist
0,234  0,141  Vasodilator, peripheral
0,116  0,024  Bile acid receptor antagonist
0,122  0,031  Triose-phosphate isomerase inhibitor
0,176  0,085  Platelet adhesion inhibitor
0,109  0,018  T cell inhibitor
0,132  0,044  Mucolytic
0,150  0,062  Contraceptive
0,138  0,051  Coagulant
0,109  0,024  Na+ K+ transporting ATPase inhibitor
0,101  0,016  Vanilloid 4 agonist
0,118  0,033  Antifungal (Aspergillus)
0,091  0,007  Dihydroorotate oxidase inhibitor
0,099  0,015  Androgen agonist
0,149  0,065  Mannose-6-phosphate isomerase inhibitor
0,134  0,050  Sphingosine 1-phosphate receptor 4 antagonist
0,139  0,056  Antismoking
0,087  0,005  5-Alpha-reductase 1 inhibitor
0,118  0,037  Opioid antagonist
0,153  0,071  CF transmembrane conductance regulator agonist
0,089  0,008  TRPM8 blocker
0,087  0,006  Retinoid X receptor agonist
0,110  0,030  Antibiotic
0,138  0,059  Sphingosine 1-phosphate receptor 2 antagonist
0,105  0,027  Keratolytic
0,203  0,125  Flavin-containing monooxygenase substrate
0,087  0,010  Postcoital contraceptive
0,082  0,005  5-Alpha-reductase 2 inhibitor
0,139  0,062  Skin whitener
0,090  0,014  Hypercalcemia treatment
0,094  0,018  CDC25B inhibitor
0,226  0,151  Apoptosis antagonist
0,087  0,011  Opioid kappa receptor agonist
0,077  0,002  Progesterone receptor B antagonist
0,112  0,039  Glutamate (mGluR7) agonist
0,084  0,012  Calcium channel P-type blocker
0,119  0,046  DOPA decarboxylase inhibitor
0,101  0,029  Purinergic P2X2 antagonist
0,123  0,052  Ferrochelatase inhibitor
0,125  0,054  Antifungal (Pneumocystis)
0,108  0,037  Antidote, mercury
0,099  0,028  GABA aminotransferase inhibitor
0,181  0,113  Antiviral (HIV)
0,097  0,029  CDC25A inhibitor
0,097  0,029  Estrogen-related receptor beta agonist
0,072  0,004  Vanilloid 3 antagonist
0,077  0,011  Ryanodine receptor antagonist
0,124  0,058  Alcohol dehydrogenase substrate
0,140  0,075  Cell wall synthesis inhibitor
0,075  0,009  Pregnane X receptor antagonist
0,082  0,018  Antihemophilic
0,084  0,020  Glutamate (mGluR6) antagonist
0,094  0,030  Narcotic antagonist
0,075  0,012  Progesterone antagonist
0,109  0,047  HIV-1 integrase (Overall Integration) inhibitor
0,071  0,009  Retinoid X alpha receptor agonist
0,177  0,115  5 Hydroxytryptamine 3E antagonist
0,125  0,063  Growth stimulant
0,169  0,108  Antihypertriglyceridemic
0,084  0,023  TRPA1 antagonist
0,076  0,015  Aconitate hydratase inhibitor
0,213  0,152  Antineoplastic (brain cancer)
0,225  0,165  Antiprotozoal (Plasmodium)
0,120  0,061  Transcription factor STAT6 inhibitor
0,118  0,059  Cystathionine beta-synthase inhibitor
0,078  0,019  Corticotropin releasing factor 2 receptor antagonist
0,185  0,128  Hypoglycemic
0,153  0,096  3C-like protease (Human coronavirus) inhibitor
0,099  0,043  Interleukin 5 antagonist
0,102  0,046  Calcium antagonist
0,087  0,032  Antidote, organophosphates
0,067  0,012  Cholesterol esterase inhibitor
0,091  0,036  CC chemokine 5 receptor agonist
0,108  0,053  UDP-glucose 4-epimerase inhibitor
0,089  0,036  Opioid mu receptor antagonist
0,117  0,064  Monophenol monooxygenase inhibitor
0,056  0,002  Vanilloid 2 agonist
0,068  0,016  Anesthetic inhalation
0,122  0,069  Aldehyde dehydrogenase inhibitor
0,058  0,006  Tubulin agonist
0,100  0,050  Antiviral (Rhinovirus)
0,071  0,023  Opioid agonist
0,135  0,088  Antidote
0,055  0,009  Retinoid X receptor antagonist
0,082  0,037  Antitreponemal
0,060  0,014  Microtubule stabilization
0,087  0,042  Sleep apnea treatment
0,231  0,186  CYP2C9 inhibitor
0,117  0,073  Antiviral (Influenza B)
0,065  0,021  Nicotinic alpha3beta2 receptor antagonist
0,108  0,066  Electron transport complex I inhibitor
0,198  0,157  Hepatic disorders treatment
0,087  0,046  Glycine receptor antagonist
0,048  0,008  Retinoid X alpha receptor antagonist
0,152  0,113  Antiviral (Influenza)
0,046  0,006  Glutamate (mGluR3) agonist
0,048  0,008  HMG CoA reductase inhibitor
0,053  0,013  Alpha 1L adrenoreceptor agonist
0,104  0,065  Glutathione S-transferase substrate
0,121  0,083  Antihemorrhagic
0,061  0,023  Opioid mu receptor agonist
0,118  0,080  Toll-Like receptor 2 antagonist
0,073  0,036  SULT2A1 substrate
0,044  0,007  Adenosine uptake inhibitor
0,067  0,031  Heme oxygenase stimulant
0,041  0,005  Nicotinic acid receptor 2 antagonist
0,175  0,139  DNA damaging
0,050  0,015  Farnesoid X receptor agonist
0,062  0,027  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,045  0,010  ATP citrate lysase inhibitor
0,092  0,057  Glutamate release inhibitor
0,081  0,046  Porphobilinogen synthase inhibitor
0,096  0,061  Lanosterol 14 alpha demethylase inhibitor
0,196  0,163  Insulysin inhibitor
0,120  0,087  Cocaine dependence treatment
0,093  0,062  Antineoplastic, alkylator
0,126  0,094  Peroxidase inhibitor
0,086  0,055  Antispirochetal
0,117  0,086  NADPH oxidase inhibitor
0,079  0,048  Analgesic, opioid
0,182  0,152  5 Hydroxytryptamine 1E antagonist
0,088  0,059  Tocolytic
0,037  0,008  Nociceptin (N/OFQ) receptor agonist
0,034  0,006  Vitamin D receptor antagonist
0,108  0,080  Mental retardation treatment
0,036  0,008  CYP24 inhibitor
0,058  0,031  Cannabinoid CB2 receptor antagonist
0,129  0,102  Sphingosine 1-phosphate receptor 5 antagonist
0,078  0,052  Estrogen receptor alpha antagonist
0,053  0,026  Aldosterone antagonist
0,121  0,095  Psychosexual dysfunction treatment
0,146  0,120  Cardiodepressant
0,042  0,018  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,172  0,148  Antineoplastic (ovarian cancer)
0,077  0,053  Nicotinic alpha4beta2 receptor antagonist
0,079  0,055  Acetylcholine nicotinic antagonist
0,092  0,068  Creatine kinase inhibitor
0,076  0,052  GABA B receptor agonist
0,057  0,033  Acetyl-CoA transferase inhibitor
0,053  0,029  Plasminogen activator inhibitor antagonist
0,045  0,021  Kainate receptor agonist
0,178  0,155  Antineurogenic pain
0,069  0,046  Neuronal nicotinic receptor antagonist
0,047  0,025  Histamine H2 receptor agonist
0,132  0,110  Heat shock protein 70 antagonist
0,027  0,005  Retinoid X beta receptor antagonist
0,186  0,165  CYP2D6 inhibitor
0,026  0,005  Nicotinic acid receptor 1 antagonist
0,071  0,050  Calcium channel L-type blocker
0,039  0,018  Peroxisome proliferator-activated receptor delta agonist
0,047  0,027  Nicotinic receptor alpha3 subunit antagonist
0,050  0,030  Cytokine production stimulant
0,058  0,039  Lipocortins synthesis agonist
0,067  0,048  MDM2 inhibitor
0,035  0,017  Cholesterol ester transfer protein antagonist
0,151  0,133  Antiulcerative
0,030  0,012  Toll-Like receptor 4 agonist
0,083  0,066  Antileprosy
0,041  0,024  GABA uptake inhibitor
0,047  0,030  Adenylate cyclase 1 inhibitor
0,163  0,147  Myocardial infarction treatment
0,030  0,014  Hedgehog signaling activator
0,194  0,178  Caspase 3 stimulant
0,032  0,016  Poly(ADP-ribose) polymerase 2 inhibitor
0,105  0,090  Shock treatment
0,094  0,079  HDL-cholesterol increasing
0,159  0,144  Vasodilator
0,058  0,043  Ca(v)3.2 blocker
0,037  0,023  Glutamate (mGluR group II) agonist
0,081  0,067  mTOR complex 2 inhibitor
0,034  0,020  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,037  0,025  Glutamate (mGluR3) antagonist
0,034  0,022  Melatonin receptor 1A agonist
0,063  0,052  Acetylcholine M5 receptor agonist
0,033  0,022  Glutamate (mGluR2) agonist
0,042  0,031  Guanylate cyclase inhibitor
0,081  0,072  NADH dehydrogenase inhibitor
0,085  0,075  ABCA1 expression enhancer
0,051  0,041  Nicotinic receptor alpha7 subunit antagonist
0,025  0,016  Sodium/glucose cotransporter 1 inhibitor
0,023  0,014  Protease (Human cytomegalovirus) inhibitor
0,017  0,008  Antibiotic Macrolide-like
0,053  0,044  Argininosuccinate synthase inhibitor
0,027  0,019  Retinoid X gamma receptor antagonist
0,014  0,006  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,022  0,015  Glutamate (mGluR1a) agonist
0,121  0,114  NOS3 expression enhancer
0,119  0,112  Skeletal muscle relaxant
0,037  0,031  Membrane dipeptidase inhibitor
0,039  0,032  Acetyl-CoA transferase 1 inhibitor
0,029  0,023  Prostaglandin D2 agonist
0,051  0,044  Alcohol oxidase inhibitor
0,032  0,026  Free fatty acid receptor 1 antagonist
0,017  0,011  Vitamin D receptor agonist
0,014  0,008  Human herpes virus 5 capsid protein P40 inhibitor
0,011  0,005  Progesterone receptor A antagonist
0,012  0,007  Calcineurin inhibitor
0,082  0,077  Thioredoxin inhibitor
0,037  0,032  Dopamine D5 agonist
0,089  0,085  Estrogen receptor beta antagonist
0,078  0,075  3C-Like protease (SARS coronavirus) inhibitor
0,021  0,018  GRP78 expression inhibitor
0,100  0,097  Myasthenia Gravis treatment
0,035  0,033  Glutamate (mGluR8) agonist
0,035  0,032  Glutamate (mGluR group II) antagonist
0,035  0,032  Delayed rectifier potassium channel blocker
0,057  0,055  Antiviral (Parainfluenza)
0,030  0,028  Nociceptin (N/OFQ) receptor antagonist
0,090  0,088  Excitatory amino acid transporter EAAC1 inhibitor
0,175  0,174  Antiviral (West Nile virus)
0,103  0,102  Cathepsin H inhibitor
0,075  0,074  GABA A receptor agonist
0,047  0,046  Cannabinoid CB2 receptor agonist
0,043  0,043  Glucose-6-phosphate isomerase inhibitor
0,134  0,134  Aldehyde oxidase substrate
0,026  0,025  Glucosylceramidase stimulant

